Angiogenic activity of sera from interstitial lung diseases patients in relation to IL-6, IL-8, IL-12 and TNFα serum level

Central-European Journal of Immunology

Volumn 32, Issue 2, 2007, Pages 53-60

  Zielonka, Tadeusz M ^a   Demkow, Urszula ^a,b   Filewska, Małgorzata ^b   Białas, Beata ^b   Korczyński, Piotr ^a   Szopiński, Janusz ^b   Soszka, Anna ^b   Skopińska Rózewska, Ewa ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

Angiogenesis; IL 12; IL 6; IL 8; Interstitial lung diseases; TNF

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FARMER LUNG; FIBROSING ALVEOLITIS; HISTIOCYTE; HUMAN; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SARCOIDOSIS; SCLERODERMA;

EID: 34249712323     PISSN: 14263912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Risau W (1997): Mechanisms of angiogenesis. Nature 386: 671-674.
2. Breier G (2000): Angiogenesis in embryonic development - a review. Placenta 21 (Suppl A): S11-S15.
3. Dunk C, Shams M, Nijar S, et al. (2000): Angiopoietin-1 and Angiopoietin-2 activate trophoblast Tie-2 to promote and migration during placenta development. Am J Pathol 156: 2185-2199.
4. Smith SK (2000): Angiogenesis and implantation. Hum Reprod 15 (Suppl 6): 59-66.
5. Hazzard TM, Stouffer RL (2000): Angiogenesis in ovarian follicular and luteal development. Baillieres Best Pract Res Clin Obstet Gynaecol 14: 883-900.
6. Witte MB, Barbul A (1997): General principles of wound healing. Surg Clin North Am 77: 509-528.
7. Hudlicka O, Brown M, Egginton S (1992): Angiogenesis in skeletal and cardiac muscle. Physiol Rev 72: 369-417.
8. Kerbel RS (2000): Tumor angiogenesis: past, present and the future. Carcinogenesis 21: 505-515.
9. Jackson JR, Seed MP, Kircher CH, et al. (1997): The codependence of angiogenesis and chronic inflammation. FASEB J 11: 457-465.
10. Spirin KS, Saghizadeh M, Lewin SL, et al. (1999): Basement membrane and growth factor gene expression in normal and diabetic human retinas. Curr Eye Res 18: 490-499.
11. Bouloumie A, Drexler HC, Lafontan M, Busse R (1998): Leptin, the product of OB. Gene, promotes angiogenesis. Circ Res 83: 1059-1066.
12. Takemura T, Hiraga Y, Oomichi M, et al. (1995): Ultrastructural features of alveolitis in sarcoidosis. Am J Respir Crit Care Med 152: 360-366.
13. Pepper MS, Mandriota SJ, Vassalli JD, et al.: Angiogenesis - regulating cytokines: activities and interactions. In: Current Topics in Microbiology and Immunology. Vol. 213/II: Attempts to Understand Metastasis Formation II. Ed. U Günthert, W Birchmeier. Spring-Verlag. Berlin Heidelberg. 1996, 31-67.
14. Yoshida S, Ono M, Shono T, et al. (1997): Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis alfa-dependent angiogenesis. Mol Cell Biol 17: 4015-4023.
15. Folkman J, Brem H: Angiogenesis and infammation. In: Inflammation: Basic Principles and Clinical Correlates. Second Edition. Ed. JI Gallin, IM Goldstein, R Snyderman. Raven Press Ltd. New York. 1992, 821-839.
16. Di Pietro LA (1997): Thrombospondin as a regulator of angiogenesis. EXS 79: 295-314.
17. Agostini C, Semenzato G (1998): Cytokines in sarcoidosis. Semin Respir Infect 13: 184-196.
18. Keane MP, Strieter RM (2002): The importance of balanced pro-inflammatory and anti-inflammatory mechanisms in diffuse lung disease. Respir Res 3: 5. Epub 2001 Oct 15.
19. Boyum A (1968): Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 97: 77-79.
20. Sidky YA, Auerbach R (1975): Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction. J Exp Med 141: 1084-1100.
21. Zielonka TM, Demkow U, Kowalski J, et al. (1997): Ocena aktywności angiogennej surowic chorych na śródmiazszowe choroby płuc. Pneumonol Alergol Pol 65: 754-760.
22. Ebina M, Shimizukawa M, Shibata N, et al. (2004): Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 169: 1203-1208.
23. Keane MP, Arenberg DA, Lynch JP 3rd, et al. (1997): The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 159: 1437-1443.
24. Weber J, Meyer KC, Banda P, et al. (1989): Studies of bronchoalveolar lavage cells and fluids in pulmonary sarcoidosis. I Enhanced capacity of bronchoalveolar lavage fluids from patients with pulmonary sarcoidosis to induced cell movement in vitro. Am Rev Respir Dis 140: 1450-1454.
25. Majewski S, Skopińska-Rózewska E, Jabłońska S, et al. (1985): Modulatory effect of sera from scleroderma patients on lymphocyte-induced angiogenesis. Arthritis Rheum 28: 1133-1139.
26. Papanicolaou D, Wilder RL, Manolagas SC, Chrousos GP (1998): The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128: 127-137.
27. Brull DJ, Sanders J, Rumley A, et al. (2002): Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release. Heart 87: 252-255.
28. Motro B, Itin A, Sachs L, Keshet E (1990): Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci U S A 87: 3092-3096.
29. Sahashi K, Ina Y, Takada K, et al. (1994): Significance of interleukin 6 in patients with sarcoidosis. Chest 106: 156-160.
30. Shimizu E, Funatsu H, Yamashita H, et al. (2002): Plasma level of interleukin-6 is an indicator for predicting diabetic macular edema. Jpn J Ophthalmol 46: 78-83.
31. Theoharides TC, Boucher W, Spear K (2002): Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol 128: 344-350.
32. Standiford TJ, Kunkel SL, Basha MA, et al. (1990): Interleukin-8 gene expression by pulmonary epithelial cell line. J Clin Invest 86: 1945-1953.
33. Koch AE, Polverini PJ, Kunkel SL, et al. (1992): Interleukine-8 (IL-8) as a macrophage-derived mediator of angiogenesis. Science 258: 1798-1801.
34. Hammond ME, Lapointe GR, Feucht PH, et al. (1995): IL-8 induced neutrophil chemotaxis predominantly via type I IL-8 receptors. J Immunol 155: 1428-1433.
35. Nickoloff BJ, Mitra RS, Varani J, et al. (1994): Aberant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol 144: 820-828.
36. Glynn PC, Henney EM, Hall IP (2001): Peripheral blood neutrophils are hyperresponsive to IL-8 and Gro-α in cryptogenic fibrosing alveolitis. Eur Respir J 18: 522-529.
37. Sinigaglia F (2000): IL-12 in lung diseases. Sarcoidosis Vasc Diffuse Lung Dis 17: 122-124.
38. Taha RA, Minshall EM, Olivenstein R, et al. (1999): Increased expression of IL-12 receptor mRNA in active pulmonary tuberculosis and sarcoidosis. Am J Respir Crit Care Med 160: 1119-1123.
39. Cavallo F, Di Carlo E, Butera M, et al. (1999): Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12. Cancer Res 59: 414-421.
40. Voest EE, Kenyon BM, O'Reilly MS, et al. (1995): Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 87: 581-586.
41. Burchett SK, Weaver MW, Westall JA, et al. (1988): Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes. J Immunol 140: 3473-3481.
42. Pantelidis P, Fanning GC, Wells AU, et al. (2001): Analysis of tumor necrosis factor-alpha, lymphotoxin- alpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 163: 1432-1436.
43. Armstrong L, Foley NM, Millar AB (1999): Inter-relationship between tumour necrosis factor-alpha (TNF-alpha) and TNF soluble receptors in pulmonary sarcoidosis. Thorax 54: 524-530.
44. Norby K (1996): TNF-alpha and de novo mammalian angiogenesis. Microvasc Res 52: 79-83.
45. Liebovich SJ, Polverini PJ, Shepard HM, et al. (1987): Macrophage-induced angiogenesis is mediated by tumor necrosis factor. Nature 329: 630-632.
46. Humar R, Kiefer FN, Berns H, et al. (2002): Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling. FASEB J 16: 771-780.